/

EU Law of Competition and Trade in the Pharmaceutical Sector

Figueroa Pablo Guerrero, Alejandro
Innbundet / 2019 / Engelsk

Produktdetaljer

ISBN
9781785362606
Publisert
2019-06-28
Utgiver
Vendor
Edward Elgar Publishing Ltd
Høyde
244 mm
Bredde
169 mm
Aldersnivå
P, 06
Språk
Product language
Engelsk
Format
Product format
Innbundet
Antall sider
864

Redaktør
Figueroa Pablo
Guerrero, Alejandro

Biographical note

Edited by Pablo Figueroa, Partner, Pérez Llorca and Lecturer, Queen Mary University, London, UK and Alejandro Guerrero, Of Counsel, Gibson, Dunn & Crutcher LLP, Belgium

EU Law of Competition and Trade in the Pharmaceutical Sector

Figueroa Pablo Guerrero, Alejandro
Innbundet / 2019 / Engelsk
Figueroa Pablo Guerrero, Alejandro
Innbundet / 2019 / Engelsk
Nettpris:
4.132,-
Laveste pris siste 30 dager: 4.132,-
Levering 7-20 dager
Klikk og hent

<i>‘The topics are very interesting, the contributions are well researched and practical in their approach and are very readable in style. A must-have book for academics and practitioners involved in the pharmaceutical sector.’ </i>

- Riccardo Sciaudone, The Competition Law Observatory,

<i>‘Impressive and comprehensive. Any practitioner, policy maker or corporate counsel with an interest in the pharmaceutical industry will find in this book a full overview of the competition and trade issues facing the sector, both from a legal and economic perspective, and covering all the major economies in the world.’</i>

- Gunnar Niels, Oxera Consulting LLP, UK,

This book provides a systematic analysis of the law and practice of EU competition/antitrust law and trade regulation in the pharmaceutical sector. Authored by leading private practitioners, economists, scholars and high-profile competition enforcers, this work provides valuable insider knowledge on the application of competition law and policies to the pharmaceutical industry. Key features include: Extensive commentary on the legislation and the latest case law and administrative precedents in the pharmaceutical sector, at both EU and national levelCoverage of various key developments including the recent pay-for-delay antitrust investigations, the perennial issues around parallel trade, and an examination of mergers among pharmaceutical companies and medical devices manufacturersIn-depth analysis of topics commonly raised in the pharmaceutical sector including: pricing policies, IP life-cycle management, IP licensing and horizontal cooperation agreementsKey economic and business perspectives to accompany legal analysis, providing the reader with a rounded view of the subject matter. This book will be a useful resource for lawyers and in-house counsel active in the pharmaceutical sector. The information and analysis provided will prepare readers to take on cases and drive the antitrust review of transactions and agreements within the industry. Researchers, economists and civil servants with an interest in competition law and trade regulation can also benefit from the practical insights provided therein.
Les mer
This book provides a systematic analysis of the law and practice of EU competition/antitrust law and trade regulation in the pharmaceutical sector.
Contents: 1. Competition Law and Pharma: An Economic Perspective Benoît Durand 2. Reverse Payments: an EU and U.S. Perspective Frank Maier-Rigaud, Nathan Blalock and Oliver Gannon 3. Article 101 TFEU: Horizontal Cooperation Agreements in the Pharmaceutical Sector Soledad Blanco Thomas, Lilia Luchianov and Thomas Weck 4. The Competitive Assessment of IP Licensing Agreements in the Pharmaceutical Sector Pierre Moullet 5. Article 102 TFEU: Patent filings as an abuse of dominant position after “AstraZeneca”: the patent / antitrust interface under a new perspective Francisco Hernández 6. Mergers in the Pharmaceutical Sector Pablo Figueroa and Alejandro Guerrero 7. Mergers in the Medical Devices Sector Jan Heithecker 8. Antitrust Practices in Pharmaceutical Public Procurement Antonio Minho López 9. EU Trade Law and Pharmaceuticals Pascale Hecker 10. The Pharmaceutical Sector and Parallel Trade Edurne Navarro Varona and Cristina Caballero 11. Free Movement and Competition in the European Market for Pharmaceuticals Pedro Caro de Sousa 12. IP Law and Pharmaceuticals: Patents and Supplementary Protection Certificates in the Pharmaceutical Sector Rais Amils 13. The EU Regulatory Framework for Medical Products for Human Use Marc Martens and Nicolas Carbonnelle 14. Antitrust and the Pharmaceutical Industry in the United States George A. Hay 15. UK Competition and Trade in the Pharma Sector Paula Riedel 16. Competition law and Pharma: China Andrew Foster 17. Competition Law and Pharma: Spain Helmut Brokelmann and Mariarosaria Ganino 18. The Application of Competition Law in the Pharmaceutical Sector: Challenges for BRICS Maria Ioannidou and Ioannis Kokkoris 19. Product Hopping: The U.S. Approach Michael A. Carrier 20. Marketing data in the Pharmaceutical Sector: a competition law consideration Pedro Callol Index
Les mer

Relaterte produkter

<i>‘The topics are very interesting, the contributions are well researched and practical in their approach and are very readable in style. A must-have book for academics and practitioners involved in the pharmaceutical sector.’ </i>

- Riccardo Sciaudone, The Competition Law Observatory,

<i>‘Impressive and comprehensive. Any practitioner, policy maker or corporate counsel with an interest in the pharmaceutical industry will find in this book a full overview of the competition and trade issues facing the sector, both from a legal and economic perspective, and covering all the major economies in the world.’</i>

- Gunnar Niels, Oxera Consulting LLP, UK,

This book provides a systematic analysis of the law and practice of EU competition/antitrust law and trade regulation in the pharmaceutical sector. Authored by leading private practitioners, economists, scholars and high-profile competition enforcers, this work provides valuable insider knowledge on the application of competition law and policies to the pharmaceutical industry. Key features include: Extensive commentary on the legislation and the latest case law and administrative precedents in the pharmaceutical sector, at both EU and national levelCoverage of various key developments including the recent pay-for-delay antitrust investigations, the perennial issues around parallel trade, and an examination of mergers among pharmaceutical companies and medical devices manufacturersIn-depth analysis of topics commonly raised in the pharmaceutical sector including: pricing policies, IP life-cycle management, IP licensing and horizontal cooperation agreementsKey economic and business perspectives to accompany legal analysis, providing the reader with a rounded view of the subject matter. This book will be a useful resource for lawyers and in-house counsel active in the pharmaceutical sector. The information and analysis provided will prepare readers to take on cases and drive the antitrust review of transactions and agreements within the industry. Researchers, economists and civil servants with an interest in competition law and trade regulation can also benefit from the practical insights provided therein.
Les mer
This book provides a systematic analysis of the law and practice of EU competition/antitrust law and trade regulation in the pharmaceutical sector.
Contents: 1. Competition Law and Pharma: An Economic Perspective Benoît Durand 2. Reverse Payments: an EU and U.S. Perspective Frank Maier-Rigaud, Nathan Blalock and Oliver Gannon 3. Article 101 TFEU: Horizontal Cooperation Agreements in the Pharmaceutical Sector Soledad Blanco Thomas, Lilia Luchianov and Thomas Weck 4. The Competitive Assessment of IP Licensing Agreements in the Pharmaceutical Sector Pierre Moullet 5. Article 102 TFEU: Patent filings as an abuse of dominant position after “AstraZeneca”: the patent / antitrust interface under a new perspective Francisco Hernández 6. Mergers in the Pharmaceutical Sector Pablo Figueroa and Alejandro Guerrero 7. Mergers in the Medical Devices Sector Jan Heithecker 8. Antitrust Practices in Pharmaceutical Public Procurement Antonio Minho López 9. EU Trade Law and Pharmaceuticals Pascale Hecker 10. The Pharmaceutical Sector and Parallel Trade Edurne Navarro Varona and Cristina Caballero 11. Free Movement and Competition in the European Market for Pharmaceuticals Pedro Caro de Sousa 12. IP Law and Pharmaceuticals: Patents and Supplementary Protection Certificates in the Pharmaceutical Sector Rais Amils 13. The EU Regulatory Framework for Medical Products for Human Use Marc Martens and Nicolas Carbonnelle 14. Antitrust and the Pharmaceutical Industry in the United States George A. Hay 15. UK Competition and Trade in the Pharma Sector Paula Riedel 16. Competition law and Pharma: China Andrew Foster 17. Competition Law and Pharma: Spain Helmut Brokelmann and Mariarosaria Ganino 18. The Application of Competition Law in the Pharmaceutical Sector: Challenges for BRICS Maria Ioannidou and Ioannis Kokkoris 19. Product Hopping: The U.S. Approach Michael A. Carrier 20. Marketing data in the Pharmaceutical Sector: a competition law consideration Pedro Callol Index
Les mer

Produktdetaljer

ISBN
9781785362606
Publisert
2019-06-28
Utgiver
Vendor
Edward Elgar Publishing Ltd
Høyde
244 mm
Bredde
169 mm
Aldersnivå
P, 06
Språk
Product language
Engelsk
Format
Product format
Innbundet
Antall sider
864

Redaktør
Figueroa Pablo
Guerrero, Alejandro

Biographical note

Edited by Pablo Figueroa, Partner, Pérez Llorca and Lecturer, Queen Mary University, London, UK and Alejandro Guerrero, Of Counsel, Gibson, Dunn & Crutcher LLP, Belgium

Relaterte produkter